Editorial: The Emerging Role for PP2A in Hematologic Malignancies

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2016.00195
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Current Role of Genetics in Hematologic Malignancies

Indian Journal of Hematology and Blood Transfusion
Hematology
2015English

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

Chylothorax in Hematologic Malignancies

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Venous Thromboembolism in the Hematologic Malignancies

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Dendritic Cell Therapies for Hematologic Malignancies

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2017English

Vaccine Therapy in Hematologic Malignancies

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

PET in the Management of Hematologic Malignancies

PET Clinics
MedicineNuclear MedicineRadiologyRadiationImaging
2019English

Bispecific Antibodies in the Treatment of Hematologic Malignancies

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

CD19-Targeted T Cells for Hematologic Malignancies

Cancer Journal
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy